Needle Protection System with Reduced Environmental Footprint!
Sustainability is playing an increasingly important role in the healthcare industry. Especially in the case of existing products, the materials and raw materials used should be evaluated and optimized in terms of their environmental compatibility.
Needle-Trap, the label with integrated needle protection from Schreiner MediPharm, is particularly sustainable compared to conventional needle safety systems. To prove the label’s sustainability, the pharma-label specialist has performed some exemplary calculations comparing Needle-Trap with conventional needle safety systems.
10 Apr 2024 - Schreiner Group: Internationally Local
The calculations were made for 10 million units of one sort for a 1 ml long syringe and represent best-case scenarios, comparing the Needle-Trap label with typical needle safety systems minus included syringes. The results provide convincing figures for the needle protection system from Schreiner MediPharm:
- 76 % less space required in cargo containers
- 76 % less transportation costs
- 80 - 83 % less CO2 emissions during transport
- 6.6 - 12.7 tons of metal savings
- 37.6 - 53 tons of plastic savings
Needle-Trap is particularly environmentally friendly primarily due to its special design: The plastic trap consisting of up to 50 % of regranulated material basically requires less plastic material than conventional needle safety systems. Due to the label’s compact design, there is no need to adjust its secondary packaging. As a result, Needle-Trap requires less space during transportation as well as storage, and generates less waste, which protects the environment and reduces the environmental footprint.
The needle protection label is delivered on rolls, eliminating the need for an additional blister pack. The grid material waste from label production is recycled.
Consequently, Needle-Trap is a more eco-conscious solution compared with conventional needle safety systems while combining safety for healthcare professionals with cost efficiency for the pharmaceutical manufacturer.
